... the New FAST(tm) Frame Multi-Slide Plate! ,FAS...our, 16-pad FAST Slides and the corresponding mult...nt for high throughput processing of microarrays. ...ended by the Society of Biomolecular Screening.,...
...onal Package Superior Protein Detection and Quant...D Proteomic Imaging System is a highly sensitive i...fe science research applications. ProXPRESS 2D pro...f all dyes in the UV and VIS spectrum range with i...
Northern BoundTM Human Alzheimer's Total RNA Blot from Sigma-Aldrich
..., Rabbit, and media. Cryo-preserved cells in mediu...pprox), supplied with kit (500 mL) of optimized me...culture, and is guaranteed to provide an additiona...lied, when used with the recommended medium. ,So...
Biology Products:(Date:11/24/2009)...ailable in Spanish . , The presence of incr...lammatory substances in the blood, hinders the los...search project of the University of Navarra conduc...e School of Pharmacy. , The project, entitled "A...o the control of body weight and inflammation," ex...
(Date:11/23/2009)... 23, 2009 - The time of day matters to forest tree...roduced by a research team led by Professor Malcol...ce-principal for research and colleagues in the de...orge campus. , Capitalizing on their previous ...research team examined how poplar trees use their ...
(Date:11/23/2009)...A new study provides "incontrovertible evidence" t...and of Sumatra about 73,000 years ago deforested m...icenter, researchers report. , The volcano eject...he atmosphere, leaving a crater (now the world,s l...and 35 kilometers wide. Ash from the event has bee...
Breaking Biology News(10 mins):It can be predicted the reaction obese patients will have to a diet 2Time of day matters to thirsty trees, U of T researcher discovers 2Supervolcano eruption -- in Sumatra -- deforested India 73,000 years ago 2Stimulus funding helps K State bring undergrads to prairie for ecology molecular biology research 9710 1Sagent Pharmaceuticals Announces Launch of Fluconazole Injection in Premix Ready to Use IV Bags 55516 1Sagent Pharmaceuticals Announces Launch of Fluconazole Injection in Premix Ready to Use IV Bags 55516 2Patient Education Summits to Address Special Challenges of Hemophilia Patients and Their Families 55512 1Patient Education Summits to Address Special Challenges of Hemophilia Patients and Their Families 55512 2Patient Education Summits to Address Special Challenges of Hemophilia Patients and Their Families 55512 3Patient Education Summits to Address Special Challenges of Hemophilia Patients and Their Families 55512 4(Date:11/24/2009)..., REYKJAVIK, Iceland, November 24 /PRNewswi...GN ) today announced the approval of all of its,"f... the District of Delaware,(the "Bankruptcy Court")...relief under Chapter 11 of the United States Bankr...he orders issued by the Bankruptcy Court allow the...
(Date:11/24/2009)... Nov. 24 Blue Marble Energy Corp. ...blic Development Authority (OPDA) were recently aw...conomic Revitalization Board (CERB) in a private/p...pecialty biochemical biorefinery in Lincoln County...speed the development of our biorefinery and bring...
(Date:11/24/2009)...LIN, November 24 Shire p...ty biopharmaceutical company, today,announced that...Agency for,velaglucerase alfa, the company,s enzym...ment of Type 1 Gaucher disease. This is the third ...has been submitted, with previous,submissions in t...
(Date:11/24/2009)... Program Connects Customers with Partners Val...th DNA Genotek Products , ...tek , a leading provider of products for biologica..., today announced its new global partner program. ...A Genotek,s partner community and is designed to h...
Breaking Biology Technology:deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 4DNA Genotek Launches Global Partner Program 2DNA Genotek Launches Global Partner Program 3